Photo

News • Oncology

Anti-inflammation approach shows promise for preventing cancer metastasis

An anti-inflammatory drug called ketorolac, given before surgery, can promote long-term survival in animal models of cancer metastasis, a team of scientists has found. Furthermore, so-called "pro-resolution" therapies can also trigger the immune system to eliminate metastatic cells. The research also suggests that flanking chemotherapy with anti-inflammatory drugs can unleash anti-tumor…

Photo

News • Macular Degeneration

Implanted drug ‘reservoir’ reduces injections

In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for…

Photo

Video • Equipment

Hygiene committed: Pentax Medical addresses the challenges in endoscopy

Recent publications have stated that several outbreaks have been caused by insufficient drying of duodenoscopes. Due to their complex design, duodenoscopes have been long recognized to require thorough processes and precise execution to properly disinfect. Read more to understand how Pentax Medical is tackling hygiene as both a challenge and priority within endoscopy.

Photo

News • Quality Assurance

A unique environment for cancer patient QA in proton therapy

IBA (Ion Beam Applications S.A.) announces the launch of myQA iON at the 2019 PTCOG conference. myQA iON significantly reduces the time needed for patient QA: The use of PT machine log files, process automation, task-based workflows, and the latest web technologies significantly increase QA efficiency while ensuring patient treatment safety. Compared to conventional detector measurements (at…

Photo

News • Oncology

Killing the unkillable cancer cells

We all know someone affected by the battle against cancer. And we know that treatments can be quite efficient at shrinking the tumor but too often, they can’t kill all the cells, and so it may come back. With some aggressive types of cancer, the problem is so great that there is very little that can be done for the patients.

Photo

News • Virtual reality

VR spots navigation problems in early Alzheimer’s disease

Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, suggests new research from the University of Cambridge. The study highlights the potential of new technologies to help diagnose and monitor conditions such as Alzheimer’s disease, which affects more than 525,000 people in the UK. In 2014, Professor John…

Photo

News • Sexually transmitted infections

New findings could improve STI vaccinations

In a new study, researchers from King’s College London have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections (STIs), such as HIV or herpes simplex virus.

Photo

News • Fake pills

'Decoy' antibiotics dupe bacteria’s defences

Imperial medical students have helped to devise a new type of ‘decoy’ drug to tackle infections that are resistant to antibiotics. In lab tests on bacterial cultures, the new drug successfully killed a strain of drug-resistant bacteria. It works by delivering two antibiotics, one of which is effectively hidden. When the bacteria fight against the first ‘decoy’ antibiotic, this action…

Photo

Sponsored • Progressing with a strong partner

Xenios and Fresenius Medical Care take the next step to multi-organ support

In October 2016, Xenios became a part of Fresenius Medical Care (FME), the world’s leading provider of products and services for people with chronic kidney failure. The integration of the expertise from FME and Xenios and thus the combination of the companies’ competences strongly enhances treatment options in critical care within the intensive care unit (ICU) of hospitals across the world.…

Photo

News • Be prepared

This 3D printed baby dummy could improve resuscitation training

Two millions: this is, worldwide, the number of babies which suffer suffocation during birth every year. A resuscitation procedure is sometimes the key to avert irreparable damages for the baby. And, for successful outcomes, promptness of action and preparation are vital. Researcher Mark Thielen (Industrial Design) from the Eindhoven University of Technology (TU/e) developed a 3D printed baby…

Photo

News • ctDNA vs. HGSOC

Taking 'molecular snapshots' of ovarian cancer

High-grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer. The HGSOC tumors consist of several heterogeneous cell populations with a large number of mutations. This genetic variability makes it difficult to find drugs that would kill all the cancer cells, and to which the cells would not become resistant during treatment. Over half of the patients…

Photo

News • Transthyretin amyloid cardiomyopathy

New treatments for rare disease ATTR-CM approved

The U.S. Food and Drug Administration (FDA) approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. Vyndaqel and Vyndamax have the same active moiety, tafamidis, but they are not substitutable on a…

Photo

News • Women's health

Endometriosis: Antibiotic could be key to treatment

Researchers at Washington University School of Medicine in St. Louis have found, in mice, that treatment with an antibiotic reduces the size of lesions caused by endometriosis. The researchers are planning a large, multicenter clinical trial to test the drug metronidazole in women who have the painful condition. The study is published online April 30 in the journal Human Reproduction.…

Photo

News • More than a symptom

Chronic pain: a real disease after all?

For the first time ever, chronic pain will be classified as a diagnosis in line with other diseases when the World Health Organization (WHO) approves the next catalogue of recognised diseases in May. According to Professor Peter Svensson from the Department of Dentistry and Oral Health, this is very significant for the approx. 20% of the population who suffer from chronic pain. Working with top…

Photo

News • Quality assurance

1,500 radiation therapy centers choose myQA

IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announced at the ESTRO 38 congress, that it has reached the milestone of 1,500 myQA customers worldwide. Since the first release of myQA in 2015, IBA has rapidly expanded its customer base across the global radiation…

1553 show more articles
Subscribe to Newsletter